Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Genentech Gains Microbe Drug Discovery Tech in $1B Deal

Collecting soil samples

Biotechnology company Genentech is licensing a process from a start-up enterprise that discovers small molecule drugs from naturally occurring microbes found in soil. . . . → Read More: Genentech Gains Microbe Drug Discovery Tech in $1B Deal

Crowdfunding Found Supporting Dubious Stem Cell Clinics

Crowdfunding graphic

More people now use crowdfunding campaigns to raise money to cover families’ medical costs, but the technique is also used to support treatments from stem cell clinics that exaggerate their outcomes and minimize their risks. . . . → Read More: Crowdfunding Found Supporting Dubious Stem Cell Clinics

Univ. Spinoff Qualifies for NIH Clinical Program

Kate Rittenhouse-Olson and John Fisk

An enterprise developing a synthetic antibody to treat breast cancer, spun-off from a University at Buffalo research lab, is taking part in a federal program to advance the treatments to clinical trials. . . . → Read More: Univ. Spinoff Qualifies for NIH Clinical Program

3-D Models Devised to Simulate Patients’ Tumors

Gioeli lab group

A university lab is teaming up with a local biotechnology company to develop realistic models of tumors from individual cancer patients, enabling more personalized treatment options. . . . → Read More: 3-D Models Devised to Simulate Patients’ Tumors

Gates Grant Funds A.I. for Malaria Drug Discovery

Giving anti-malaria drugs

An award from the Bill and Melinda Gates Foundation is supporting research by a digital drug discovery company and university lab into use of artificial intelligence to find new drugs for treating malaria. . . . → Read More: Gates Grant Funds A.I. for Malaria Drug Discovery

Trial Underway Testing Universal Flu Vaccine

Influenza virus

A clinical trial is recruiting participants to test a vaccine to protect against a variety of influenza strains, instead of today’s vaccines designed to prevent infections from specific strains expected in a given year. . . . → Read More: Trial Underway Testing Universal Flu Vaccine

New Cell Therapy Company Raises $58.5M in Early Funds

Investment graphic

A start-up enterprise is discovering therapies to address a variety of disorders that result from faulty cell degradation processes known as autophagy, which when functioning normally contribute to cell health. . . . → Read More: New Cell Therapy Company Raises $58.5M in Early Funds

Cellectis, Wyss Inst. Partner on Recoding Human Genome

DNA puzzle

A bioengineering center at Harvard University and a biotechnology company are creating a process for genetically editing human cell lines to produce virus-resistant synthetic proteins for research and therapies. . . . → Read More: Cellectis, Wyss Inst. Partner on Recoding Human Genome

Nasal Spray Vaccine Shown to Control Peanut Allergies

A vaccine to protect against peanut allergies, given as a nanoscale droplets suspended in a nasal spray, is shown to prevent allergic reactions in tests with lab mice sensitized to peanuts. . . . → Read More: Nasal Spray Vaccine Shown to Control Peanut Allergies

Gene Therapy Biotech Acquired in $8.7 Billion Deal

A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal